|
|||||||||||||||||||||||||||||||||||||||||||
|
|
Key: Meeting
Showing releases 101-125 out of 130. << < 1 | 2 | 3 | 4 | 5 | 6 > >>
Public Release: 27-Jun-2013
ASTRO Chairman Michael Steinberg, M.D., FASTRO, reaffirms Society's commitment to ending self-referral Michael L. Steinberg, M.D., FASTRO, chairman of the American Society for Radiation Oncology's Board of Directors, states that Dr. Jacobs, et al.'s study reaffirms the Society's commitment to closing the self-referral loophole for radiation therapy within the Ethics in Patient Referrals Act, also known as the self-referral law. Contact: Michelle Kirkwood Public Release: 27-Jun-2013
California governor signs budget bringing UCR School of Medicine long-sought state funding A budget compromise worked out and signed today by California Governor Jerry Brown means that the UC Riverside School of Medicine will receive full and continuous funding of $15 million per year -- long-sought assistance that enables the school to flourish and greatly facilitates its ongoing accreditation. Funding for the UCR medical school will now be part of the University of California's base budget annually going forward. Contact: Iqbal Pittalwala Public Release: 27-Jun-2013
University Hospitals Eye Institute to offer 'first bionic eye' retinal chip for blind University Hospitals Eye Institute will be one of the first medical centers in the United States to offer the Argus® II Retinal Prosthesis System ("Argus II"). The Argus II is the first and only "bionic eye" to be approved in countries throughout the world, including the US. It is used to treat patients with late stage retinitis pigmentosa. Argus II was developed by Second Sight Medical Products, Inc., located near Los Angeles. Contact: George Stamatis Public Release: 27-Jun-2013
New genomics research project to eliminate Listeria from food supply Genome Canada, the Canadian Food Inspection Agency, and Alberta Innovates Bio Solutions have partnered to support a $1.4 million project that will help protect consumers from Listeriosis, a serious foodborne illness caused by Listeria bacteria. Contact: Andrea Matyas Public Release: 27-Jun-2013
In the quest for excellence in machine translation The IXA Group of the UPV/EHU-University of the Basque Country has just embarked on a new European project to take a qualitative leap forward in machine translation: QT Leap. The project aims to significantly improve the quality of today's results in machine translation, which are far from perfect. The project has a duration of three years. Contact: Irati Kortabitarte Public Release: 27-Jun-2013
Elsevier announces the publication of Health Care: The Journal of Delivery Science and Innovation Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the publication of the first issue of Health Care: The Journal of Delivery Science and Innovation. Contact: James Palser Public Release: 26-Jun-2013
Bluefin tuna experts dispute assessment of fish populations Leading Bluefin tuna researchers at the universities of Massachusetts and Maine issued a rebuttal to a "fact sheet" they say is an "irresponsible distortion of the information available" issued by the Pew Charitable Trusts this week, as the International Commission for the Conservation of Atlantic Tuna's expert working groups meet in Montreal beginning today to discuss tuna stocks. Contact: Janet Lathrop Public Release: 26-Jun-2013
American Cancer Society journal reaches top ranking among all journals The American Cancer Society flagship journal, CA: A Cancer Journal for Clinicians, has been ranked with the highest impact factor on record for any journal recorded in the ISI Journal Citation Reports. Contact: David Sampson Public Release: 26-Jun-2013
CU-Boulder joins Sloan Digital Sky Survey to map stars, galaxies and quasars in 3-D The University of Colorado Boulder has become a full institutional member of the Sloan Digital Sky Survey-IV, an ambitious effort by some of the world's top astronomers to map the celestial sky in three dimensions to learn more about the structure and evolution of the universe. Contact: Michael Shull Public Release: 26-Jun-2013
Ben-Gurion U. and UChicago research collaboration targets water resource innovations The first wave of research proposals include fabricating new materials tailored to remove contaminants, bacteria, viruses, and salt from drinking water at a fraction of the cost of current technologies; biological engineering that will help plants maximize their own drought-resistance mechanisms; and polymers that can change the water retention properties of soil in agriculture. Contact: Andrew Lavin Public Release: 26-Jun-2013
Announcing the Community for Zero Hunger At the 2012 Rio+20 Conference, United Nations Secretary-General Ban Ki-moon unveiled the Zero Hunger Challenge. He called upon all sectors to step up the fight against hunger and malnutrition. As an independent response to that call to action, the Community for Zero Hunger was launched on June 26, 2013. Contact: Erica Oakley Public Release: 26-Jun-2013
Pufferfish neurotoxin may serve as treatment for cancer therapy related pain Researchers at the Brain and Spine Institute at John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, are studying a possible alternative to side effect-ridden opioid-based medications to treat cancer-related pain. The active ingredient for the treatment is Tetrodotoxin, a neurotoxin found in pufferfish. Contact: Jon Byington Public Release: 26-Jun-2013
Faculty of 1000 announces partnership between F1000Prime and docwise F1000Prime recommendations to appear in docwise's personalized aggregated reader platform for physicians. Contact: Eleanor Howell Public Release: 26-Jun-2013
New €6.1million project to develop new antifungal agents to treat resistant fungal infections The University of Manchester and F2G Ltd, a privately-held antifungal drug discovery and development company and today announced the start of a 6.1 million euro EU-funded project to discover and develop novel antifungal drugs to treat serious, life-threatening fungal infections. The NOFUN project is a collaborative project under the 7th Framework Program of the European Commission which brings together five partners to accelerate the development of a number of F2G's broad spectrum antifungal agents. Contact: Alison Barbuti Public Release: 25-Jun-2013
The buffer stops here A new technology developed by researchers at the Polytechnic Institute of New York University may make spotty streaming and data-hogging downloads a thing of the past. The patent-pending technique, called streamloading, in the simplest terms makes use of a video format that splits the video into two layers -- a base layer, which contains a coarse representation of the video, and an enhancement layer, which completes the image quality and includes the fine-grain details. Contact: Kathleen Hamilton Public Release: 25-Jun-2013
DOE, NREL announce new research center to boost clean energy technologies on a smarter grid The Energy Department and the National Renewable Energy Laboratory today announced the Energy Systems Integration Facility in Golden, Colorado, as the latest Energy Department user facility and the only one in the nation focused on utility-scale clean energy grid integration. The facility's first industry partner -- Colorado-based Advanced Energy Industries -- has already signed on to start work at ESIF, developing lower cost, better performing solar power inverters. Contact: David Glickson Public Release: 25-Jun-2013
NREL drives toward the future with fuel cell EVs Efforts currently underway at the Energy Department's National Renewable Energy Laboratory are contributing to rapid progress in the research, development and testing of hydrogen and fuel cell technologies. Contact: David Glickson Public Release: 25-Jun-2013
New IT tool predicts book sales prior to publication The system goes through a learning phase, considering data on thousands of previously published books, to obtain a mathematical model capable of estimating probable sales. Contact: Pedro Ángel Castillo-Valdivieso Public Release: 25-Jun-2013
Haydale announce breakthrough graphene inks to accelerate graphene applications Haydale, a leader in facilitating the commercial application of graphenes announces that with its development partner, Gwent Electronic Materials, it has developed graphene based inks with properties that now quickly enable its customers to use graphene in a wide range of applications. These new graphene inks enable the commercialization in the near future of smart packaging, printed batteries, electrochemical sensors, flexible displays and potentially touch screens. Contact: Trevor Phillips Public Release: 25-Jun-2013
New Finnish solution shortens power cuts during storms VTT Technical Research Centre of Finland has developed a tool that can be used to shorten power cuts caused by storms and to reduce the resulting costs and damage, such as faults in household electrical appliances and frozen water pipes. Contact: Pertti Raatikainen Public Release: 25-Jun-2013
TGen and Ventana Medical Systems Inc. join forces to fight cancer The Translational Genomics Research Institute and Ventana Medical Systems Inc., a member of the Roche Group, today announced a collaborative research agreement to discover and develop diagnostic markers for treating cancer. The two Arizona-based institutions will leverage each other's expertise in discovery and diagnostic product development, bringing innovative cancer diagnostic tests to patients. Contact: Steve Yozwiak Public Release: 25-Jun-2013
Lauren Sciences LLC awarded second Michael J. Fox Foundation grant to further develop V-Smart™ Therapeutic for Parkinson's disease Lauren Sciences LLC, a privately-held biotechnology company continuing development of its novel V-Smart™ platform technology, announced today the award of a second grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF). The company recently completed the first stage of developing V-Smart™-based therapeutics for the treatment of Parkinson's disease (PD), which was funded by MJFF, whereby it demonstrated targeted delivery of GDNF (glial-derived neurotrophic factor) to brain regions in which neurons degenerate during the course of PD. Contact: Susan Rosenbaum Public Release: 24-Jun-2013
Part-time graduate enrollment in science and engineering growing at a higher rate From 2010 to 2011, enrollment of part-time graduate students in science and engineering (S&E) fields grew at a higher rate than that of full-time S&E graduate students for the first time since 2005. Contact: Deborah Wing Public Release: 24-Jun-2013
Notre Dame and Harper researchers developing novel method to test for HPV and oral cancers Research being carried out at the University of Notre Dame and its affiliated Harper Cancer Research Institute may lead to the development of a rapid, cost-effective means of screening for oral cancers and the human papillomavirus. Contact: Sharon Stack Public Release: 24-Jun-2013
Desktop experiment kit improves engineering ed Washington State University researchers joined forces with Armfield Ltd., a teaching equipment company, to launch a desktop learning module (DLM) that will improve engineering education. The DLM was initially developed by Bernard Van Wie, professor in the Gene and Linda Voiland School of Chemical and Bioengineering, and his students and colleagues. It is a desktop apparatus with multiple, easily removable cartridges that can be reconfigured to perform experiments. Contact: Alyssa Patrick
Showing releases 101-125 out of 130. << < 1 | 2 | 3 | 4 | 5 | 6 > >>
|